Countless studies have highlighted the industrial and medicinal uses of marijuana (cannabis), yet the federal government claims that it has ‘no accepted medical use’ and continues to classify it in the same category as heroin, MDMA, and PCP. Despite the ruling, the medial marijuana market is priced at around $1.7-billion — that’s almost as much as the explosive Viagra market, coming in at around $1.9 billion.
Studies have found marijuana use to be beneficial in treating multiple sclerosis, Tourette syndrome, obsessive-compulsive disorder, brachial plexus neuropathies, insomnia, pain, memory disorders, anxiety disorders, cancer, neurodegenerative disease, and many more conditions.




Texas cotton grower Brad Heffington speaks Wall Street's language of hedges, correlation charts and the like as easily as he discusses weevils and pesticides. Yet today his financial knowledge is of limited use.
How would you feel knowing that the doctor insisting that smoking is completely safe is actually being paid by the tobacco industry? This kind of information would be extremely off-putting to say the least. But unfortunately this conflict of interest is absolutely rampant among the mainstream health community, especially in the pharmaceutical industry. In fact, recent news has come out revealing that thousands of doctors, researchers, and medical experts in Texas are being paid handsomely by the pharmaceutical industry.





























